RNA-Seq Differentiates Tumour and Host mRNA Expression Changes Induced by Treatment of Human Tumour Xenografts with the VEGFR Tyrosine Kinase Inhibitor Cediranib
about
Decoding breast cancer tissue-stroma interactions using species-specific sequencingDisambiguate: An open-source application for disambiguating two species in next generation sequencing data from grafted samples.Transcriptional dissection of pancreatic tumors engrafted in mice.Long-term safety issues of iPSC-based cell therapy in a spinal cord injury model: oncogenic transformation with epithelial-mesenchymal transition.Consensus Analysis of Whole Transcriptome Profiles from Two Breast Cancer Patient Cohorts Reveals Long Non-Coding RNAs Associated with Intrinsic Subtype and the Tumour Microenvironment.CASTIN: a system for comprehensive analysis of cancer-stromal interactome.Whole transcriptome profiling of patient-derived xenograft models as a tool to identify both tumor and stromal specific biomarkersEffective combination therapies in preclinical endocrine resistant breast cancer models harboring ER mutations.Honokiol Decreases Lung Cancer Metastasis through Inhibition of the STAT3 Signaling Pathway.Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts.Tracking cellular and molecular changes in a species-specific manner during experimental tumor progression in vivo.
P2860
Q30986777-59E2B655-24F2-426E-9680-0EAB563A9544Q31149878-D252BBE5-F4A2-4A1D-BC73-249E01F82D95Q33772571-C1ABE59E-C989-4A4D-ADC5-6AF6D4787C07Q34462874-B0664464-C6BF-4EBD-8BA8-6079086C7A38Q36148711-56747855-4C21-403A-82DD-53B3A5A3F1FCQ36187726-ED3312B8-F456-47BD-8E2D-2D89173CAF80Q37190437-F013B43A-B5C3-4412-9E13-4C8FEBDBB26FQ37688020-146CEE44-303B-48A0-9824-36CB195F917AQ48428544-5E93DD45-624F-4E5B-ADEF-F9EFCF9ABD52Q49547506-F4AF2A9F-0E36-4E98-8FE9-5B7C8D8DF08EQ52319522-08A41411-E77C-4D49-BD51-B1B4AE7A593F
P2860
RNA-Seq Differentiates Tumour and Host mRNA Expression Changes Induced by Treatment of Human Tumour Xenografts with the VEGFR Tyrosine Kinase Inhibitor Cediranib
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
RNA-Seq Differentiates Tumour ...... ine Kinase Inhibitor Cediranib
@ast
RNA-Seq Differentiates Tumour ...... ine Kinase Inhibitor Cediranib
@en
RNA-Seq Differentiates Tumour ...... ine Kinase Inhibitor Cediranib
@nl
type
label
RNA-Seq Differentiates Tumour ...... ine Kinase Inhibitor Cediranib
@ast
RNA-Seq Differentiates Tumour ...... ine Kinase Inhibitor Cediranib
@en
RNA-Seq Differentiates Tumour ...... ine Kinase Inhibitor Cediranib
@nl
prefLabel
RNA-Seq Differentiates Tumour ...... ine Kinase Inhibitor Cediranib
@ast
RNA-Seq Differentiates Tumour ...... ine Kinase Inhibitor Cediranib
@en
RNA-Seq Differentiates Tumour ...... ine Kinase Inhibitor Cediranib
@nl
P2093
P2860
P3181
P1433
P1476
RNA-Seq Differentiates Tumour ...... ine Kinase Inhibitor Cediranib
@en
P2093
Helen Brown
Jonathan R Dry
Mark Wappett
Matthew Farren
Neil J Gibson
Neil R Smith
Oona Delpuech
Sarah Runswick
Simon T Barry
Steve J Powell
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0066003
P407
P577
2013-06-19T00:00:00Z